Koers Can Fite Biopharma Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0010944739
Farmaceutische producten
Omzet 2024 * | 900K 327 mln. 826K | Omzet 2025 * | 900K 327 mln. 826K | Marktkapitalisatie | 18,3 mln. 6,65 mld. 16,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -7 mln. -2,54 mld. -6,42 mln. | Nettowinst (verlies) 2025 * | -8 mln. -2,91 mld. -7,34 mln. | EV/omzet 2024 * | 20,3 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 20,3 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,97% |
Recentste transcriptie over Can Fite Biopharma Ltd
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01-08-03 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Ilan Cohn
FOU | Founder | 68 | 11-09-94 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01-01-01 |
Ilan Cohn
FOU | Founder | 68 | 11-09-94 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,40% | 101 mld. | |
+7,76% | 42,18 mld. | |
-14,37% | 32,26 mld. | |
+80,29% | 29,79 mld. | |
-12,27% | 16,06 mld. | |
+2,33% | 14,45 mld. | |
-8,56% | 12,01 mld. | |
+182,74% | 10,71 mld. | |
+4,72% | 8,89 mld. |